Tissue injury after lithium treatment in human and rat postnatal kidney involves glycogen synthase kinase-3β-positive epithelium
Authors:
Open Access
- 15 February 2012
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 302 (4) , F455-F465
Abstract
It was hypothesized that lithium causes accelerated and permanent injury to the postnatally developing kidney through entry into epithelial cells of the distal nephron and inhibition of glycogen synthase kinase-3β (GSK-3β). GSK-3β immunoreactivity was associated with glomeruli, the thick ascending limb of Henle's loop, and collecting ducts in the developing and adult human and rat kidney. In rats, the abundance of inactive, phosphorylated GSK-3β (pGSK-3β) protein decreased during postnatal development. After feeding of dams with litters lithium [50 mmol Li/kg chow, postnatal (P) days 7–28], the offspring showed plasma lithium concentration of 1.0 mmol/l. Kidneys from lithium-treated rat pups exhibited dilated distal nephron segments with microcysts. Stereological analysis showed reduced cortex and outer medullary volumes. Lithium increased pGSK-3β and the proliferation marker proliferating cell nuclear antigen (PCNA) protein abundances in the cortex and medulla. After lithium treatment, pGSK-3β-immunopositive cells exhibited restricted distribution and were associated primarily with subsets of cells in dilated and microcystic segments of cortical collecting ducts. After 6 wk of lithium discontinuation, adult rats exhibited attenuated urine concentration capacity and diminished outer medullary volume. Histological sections of two nephrectomy samples and a biopsy from three long-term lithium-treated patients showed multiple cortical microcysts that originated from normally appearing tubules. Microcysts were lined by a cuboidal PCNA-, GSK-3β-, and pGSK-3β-immunopositive epithelium. The postnatal rat kidney may serve as an experimental model for the study of lithium-induced human kidney injury. The data are compatible with a causal relationship between epithelial entry of lithium into cells of the aldosterone-sensitive distal nephron, inactivation of GSK-3β, proliferation, and microcysts.Keywords
This publication has 39 references indexed in Scilit:
- αENaC-Mediated Lithium Absorption Promotes Nephrogenic Diabetes InsipidusJournal of the American Society of Nephrology, 2011
- GSK3β Mediates Renal Response to Vasopressin by Modulating Adenylate Cyclase ActivityJournal of the American Society of Nephrology, 2010
- Angiotensin II Promotes Development of the Renal Microcirculation through AT1 ReceptorsJournal of the American Society of Nephrology, 2010
- Expression of transporters involved in urine concentration recovers differently after cessation of lithium treatmentAmerican Journal of Physiology-Renal Physiology, 2010
- Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: Mechanisms for aquaporin 2 down-regulation and cellular proliferationProceedings of the National Academy of Sciences, 2008
- Lithium toxicity: A double-edged swordKidney International, 2008
- Cell proliferation and morphometric changes in the rat kidney during postnatal developmentBrain Structure and Function, 2002
- Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsCurrent Biology, 1996
- Effect of dietary sodium content on renal handling of lithiumPflügers Archiv - European Journal of Physiology, 1986
- Functional and Structural Changes in the Rat Kidney by Long-Term Lithium TreatmentKidney and Blood Pressure Research, 1982